Evaluation of GPT-3 for Anti-Cancer Drug Sensitivity Prediction

09/18/2023
by   Shaika Chowdhury, et al.
0

In this study, we investigated the potential of GPT-3 for the anti-cancer drug sensitivity prediction task using structured pharmacogenomics data across five tissue types and evaluated its performance with zero-shot prompting and fine-tuning paradigms. The drug's smile representation and cell line's genomic mutation features were predictive of the drug response. The results from this study have the potential to pave the way for designing more efficient treatment protocols in precision oncology.

READ FULL TEXT
research
05/20/2018

Predicting drug response of tumors from integrated genomic profiles by deep neural networks

The study of high-throughput genomic profiles from a pharmacogenomics vi...
research
07/10/2022

TCR: A Transformer Based Deep Network for Predicting Cancer Drugs Response

Predicting clinical outcomes to anti-cancer drugs on a personalized basi...
research
04/13/2023

Effect of hydraulic conductivity and permeability on drug distribution, an investigation based on a part of a real tissue

In this study, a computational simulation is employed to place two essen...
research
05/09/2017

Improving drug sensitivity predictions in precision medicine through active expert knowledge elicitation

Predicting the efficacy of a drug for a given individual, using high-dim...
research
10/09/2020

A Cross-Level Information Transmission Network for Predicting Phenotype from New Genotype: Application to Cancer Precision Medicine

An unsolved fundamental problem in biology and ecology is to predict obs...
research
09/09/2020

Investigation of REFINED CNN ensemble learning for anti-cancer drug sensitivity prediction

Anti-cancer drug sensitivity prediction using deep learning models for i...

Please sign up or login with your details

Forgot password? Click here to reset